Obstructive emphysema
Obstructive pulmonary emphysema is a disease characterized by persistent expansion and dilation of the distal air sac cavity of the terminal bronchioles (including respiratory bronchioles, alveolar ducts, alveolar sacs and alveoli), accompanied by destruction of the air cavity wall structure without obvious fibrosis. This disease is often caused by chronic bronchitis induced by long-term smoking, air pollution, inhalation of harmful chemicals and dust, and chronic recurrent respiratory tract infections, which further develop into this disease.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Smokers and chronic bronchitis patients -
Related symptoms:
Barrel chest Chest tightness Dyspnea on exertion Decreased breath sounds Shortness of breath -
Concurrent disease:
Related Drugs
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Harbin Pharmaceutical Group Pharmaceutical Factory No.6
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Yichang Humanwell Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Qingdao Huanghai Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Yunnan Yong'an Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Changchun Changqing Pharmaceutical Group Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Inner Mongolia Haitian Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Tianjin Lisheng Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Tianjin Lisheng Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Tianjin Lisheng Pharmaceutical Co., Ltd.
Related Ingredients